Ceritinib

Overview

Ceritinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2403108).

API suppliers (1)

Suppliers of Ceritinib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN Laboratories Private LimitedIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Ceritinib expires 13 Dec 2037. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine

Canonical SMILES

CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl

InChIKey

VERWOWGGCGHDQE-UHFFFAOYSA-N